Text Registration
Copyright Title
Molecular therapy for mucopolysaccharidosis type i
Status
Published
on 9 Aug 2013
Year of Creation
2010
Copyright Claimant
Daniel Adam Wolf
Registration Number
TX0006765618
on 9 Aug 2013Copyright Summary
The U.S. Copyright record (Registration Number: TX0006765618) dated 9 Aug 2013, pertains to an electronic file (eService) titled "Molecular therapy for mucopolysaccharidosis type i" created in 2010. The copyright holder is Daniel Adam Wolf, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Daniel Adam Wolf.
Application Details
Registration Number
TX0006765618
Registration Date
8/9/2013
Year of Creation
2010
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Computer text data
Notes
Rights Note: Rights and permissions info. on CORDS appl. in CO
Local Copyright Note: Electronic registration
Statements
Author Statement: entire text: Daniel Adam Wolf
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.